LexDanaLexDanabeta
Inventor

BRETT P. MONIA

Inventor
US

Overview

4→
Patents
2022–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C12NMicroorganisms or enzymes25%
C07HSugars13%
C07KPeptides6%
C12YEnzymes6%
PatentTitleYear
12,496,311Methods for safely reducing thrombopoietin202512,115,225GLP-1 receptor ligand moiety conjugated oligonucleotides and uses thereof202411,535,849Modulation of transthyretin expression202211,376,273Modulation of factor 11 expression2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2025Patents assigned to IONIS PHARMACEUTICALS INC (4)· patent assignee history
2022–2025Based in US· patent location history
2024Patents assigned to ASTRAZENECA AB (1)· patent assignee history
2025Patents assigned to ARONORA INC (1)· patent assignee history
2025Patents assigned to UNIV OREGON HEALTH & SCIENCE (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
IONIS PHARMACEUTICALS INC42022–2025
ARONORA INC12025
ASTRAZENECA AB12024
UNIV OREGON HEALTH & SCIENCE12025
Locations
LocationPatentsSpan
US42022–2025